Apr 1 2011;90(1):122-129
doi: 10.3390/antiox10010064 24 NewsholmePCruzatVFKeaneKNCarlessiRde BittencourtPIH
Peptide mixtures from each sample were injected into an Acclaim PepMap100 C18 trap column (3 m particle size, 100 pore size, 75 m internal diameter, and 20 mm column length), which was connected to an analytical Acclaim PepMap column (2 m particle size, 100 pore size, 150 mm length, and 50 m internal diameter), with a flow rate of 200 nL/min
607 A randomized, double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological, and clinical measures in patients with T2DM with symptomatic polyneuropathy is undergoing
doi: 10.1016/j.diii.2022.09.009 9 ArcigaBMWaltersDMKimchiETStaveley-O'CarrollKFLiGTeixeiroEet al